524663 — Bharat Immunologicals and Biologicals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.01bn
- IN₹1.68bn
- IN₹446.09m
Annual cashflow statement for Bharat Immunologicals and Biologicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -73.7 | -142 | -142 | -96.9 | -229 |
| Depreciation | |||||
| Non-Cash Items | -2.39 | 38.4 | 38.4 | 50.6 | 65.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -249 | 442 | 442 | -377 | 270 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -322 | 341 | 341 | -421 | 109 |
| Capital Expenditures | -0.251 | -0.005 | -0.005 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.23 | 9.13 | 9.13 | 5.31 | 4.62 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.98 | 9.12 | 9.12 | 5.31 | 4.62 |
| Financing Cash Flow Items | -15.2 | -52.3 | -52.3 | -55.9 | -70.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 307 | -344 | -344 | 450 | -147 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.9 | 5.77 | 5.77 | 34.2 | -33.6 |